HC
TAK icon

Henshaw Capital’s Takeda Pharmaceutical TAK Stock Holding History

Henshaw Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,391
Closed -$542K – 352
2020
Q3 		$542K Hold
30,391
– – 0.04% 144
2020
Q2 		$545K Hold
30,391
– – 0.05% 138
2020
Q1 		$461K Buy
30,391
+4,839
+19% +$87.7K 0.05% 143
2019
Q4 		$504K Hold
25,552
– – 0.04% 144
2019
Q3 		$439K Buy
25,552
+791
+3% +$13.7K 0.04% 154
2019
Q2 		$438K Buy
24,761
+6,111
+33% +$111K 0.04% 155
2019
Q1 		$380K Hold
18,650
– – 0.03% 175
2018
Q4 		$314K Buy
+18,650
New +$315K 0.03% 182

Other funds holding TAK

GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM